Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/677
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPark, W.en
dc.contributor.authorStrusberg, I.en
dc.contributor.authorAmante, Ericen
dc.contributor.authorXu, W.en
dc.contributor.authorRahman, M. U.en
dc.contributor.authorHsia, E. C.en
dc.contributor.authorPons-Estel, B.en
dc.contributor.authorChurchill, M.en
dc.contributor.authorMoreland, L. W.en
dc.contributor.authorEmery, P.en
dc.contributor.authorFleischmann, R. M.en
dc.contributor.authorDurez, P.en
dc.contributor.authorNasi, P.en
dc.date.accessioned2018-06-16T20:36:49Z-
dc.date.available2018-06-16T20:36:49Z-
dc.date.issued2008-
dc.identifier.citationSep 58, (9), 2008, p. S530-S530en
dc.identifier.otherRIS-
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/677-
dc.description.abstract72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-ProfessionalsOCT 24-29, 2008 <br />San Francisco, CA <br />Suppl. S <br />en
dc.languageenen
dc.relation.ispartofArthritis and Rheumatismen
dc.titleGolimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE studyen
dc.typeArticleen
dc.identifier.doi272-
dc.relation.url<Go to ISI>://000259244201243en
dc.identifier.risid272en
dc.description.pagesS530-S530en
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

454
checked on May 21, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.